$ENVA

TEBBE MARK sold $4.0M of ENVA

TEBBE MARK sold 20,000 shares of Enova International, Inc. (ENVA) at $201.37 ($4.03M total) on 2026-06-18.

Original reporting
SEC EDGAR · TEBBE MARK
Published Jun 23, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 23, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ENVA
Neutral
medium confidence
Mentioned
$ENVA
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ENVANeutralLow
01

Why it matters

This is a primary-source disclosure of an insider sale. It can modestly influence short-term sentiment, but it does not introduce new operational, financial, or regulatory information about ENVA.

02

Market read

Traders may monitor whether this sale is part of a broader pattern, but the filing alone is unlikely to drive a durable repricing.

03

What to watch

Form 4 sales often have non-informational drivers; without additional context (e.g., repeated sales, size vs. typical activity, or concurrent operational news), the trading signal is weak.

Relevance 6/10Novelty 3/10Timing: after-hours/filing timestamp (2026-06-23) for the 2026-06-18 sale disclosure

Background

SEC Form 4 insider transaction for Enova International, Inc. (ENVA): director TEBBE MARK sold 20,000 shares at $201.3680 on 2026-06-18; filing made 2026-06-23.

Company-level read

Ticker impact

$ENVANeutralMedium confidence
Context

Enova director TEBBE MARK filed a Form 4 selling 20,000 shares at $201.3680 on 2026-06-18, totaling ~$4.03M.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless accompanied by other news.

Evidence & confidence

The filing is a disclosed sale (not a buy), but it provides no new company fundamentals, guidance, or transaction terms beyond the trade size and price.

Market effects

No clear sector read-through; this is an individual insider transaction without stated company-wide developments.

None indicated.

None indicated.

Counterpoint

The sale could be planned liquidity (even though the filing notes no pre-arranged 10b5-1 plan), personal diversification, or tax-related selling rather than a bearish signal.

Key entities

  • Enova International, Inc.

    Company whose director filed the Form 4 insider sale.

  • TEBBE MARK

    Director who sold 20,000 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ENVAMed

Citizens Cuts Enova’s Price Target after its Bank Deal Falls Apart

Citizens analyst David Scharf cut Enova's (NYSE:ENVA) price target to $215 from $270 after it abandoned a bank acquisition deal. Enova cited unclear standards and slow approvals. The company reaffirmed its guidance for 25% revenue growth and 30% adjusted EPS growth in Q3. For the full year, it expects 20-25% revenue growth and 30-35% adjusted EPS growth. Enova reported strong Q2 results with 22% revenue growth and 33% adjusted EPS growth. The company plans to accelerate share repurchases.

$ENVAMed

Why Enova International Stock Was Plummeting This Week

Enova International (NYSE: ENVA) withdrew applications for banking licenses, causing its stock to drop nearly 20% week-to-date. The company cited unclear authorization processes and plans to focus on its existing business. Enova reaffirmed its 2026 revenue growth forecast of 20-25% and adjusted net income per share growth of 30-35%.